🇺🇸 FDA
Preview mode — showing bulk-ingested data not yet promoted to production. Hide preview

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
3,385
Companies
1,062
Pipeline programs
18,156

Quick answer

NovaPharmaNews tracks 3,385 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

122 results for “VIR” Clear

  1. daclatasvir dihydrochloride

    DAKLINZA

    ORAL approved

  2. darunavir

    DARUNAVIR KRKA Amneal Pharma Europe Ltd

    ORAL approved

    J05AE10

  3. darunavir and cobicistat

    PREZCOBIX

    ORAL approved

  4. darunavir and ritonavir

    DARUNAVIR AND RITONAVIR

    ORAL approved

  5. darunavir ethanolate

    DARUNAVIR ETHANOLATE

    ORAL approved

  6. dasabuvir

    EXVIERA

    J05AP09

  7. dasabuvir sodium

    VIEKIRA PAK (COPACKAGED)

    ORAL approved

  8. delavirdine mesylate

    RESCRIPTOR

    ORAL approved

  9. dolutegravir

    DOVATO Sana Biotechnology

    ORAL approved

    J05AR

  10. dolutegravir and lamivudine

    DOLUTEGRAVIR AND LAMIVUDINE

    approved

  11. dolutegravir lamivudine tenofovir alafenamide

    DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE

    approved

  12. dolutegravir sodium

    DOLUTEGRAVIR SODIUM

    ORAL approved

  13. dolutegravir, emtricitabine and tenofovir alafenamide

    DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL approved

  14. doravirine

    DELSTRIGO

    ORAL approved

    J05AG06

  15. efavirenz

    EFAVIRENZ TEVA Teva Pharma GmbH

    ORAL approved

    J05AR06

  16. efavirenz, emtricitabine and tenofovir alafenamide

    EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL approved

  17. elbasvir

    ZEPATIER

    ORAL approved

    J05AP54

  18. elvitegravir

    GENVOYA

    ORAL approved

    J05AR

  19. elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide

    ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    approved

  20. emtricitabine, tenofovir alafenamide

    EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL approved

  21. enfuvirtide

    FUZEON

    SUBCUTANEOUS approved

    J05AX07

  22. entecavir

    BARACLUDE Amneal Pharma Europe Ltd

    ORAL approved

    J05AF10

  23. etravirine

    INTELENCE Amneal Pharma Europe Ltd

    ORAL approved

    J05AG04

  24. faldaprevir

    FALDAPREVIR BOEHRINGER INGELHEIM

    J05AE

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,385 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources